Skip to main content
Citi Pharma Ltd. logo

Citi Pharma Ltd. — Investor Relations & Filings

Ticker · CPHL ISIN · PK0126201018 PSX Manufacturing
Filings indexed 101 across all filing types
Latest filing 2025-10-16 Regulatory Filings
Country PK Pakistan
Listing PSX CPHL

About Citi Pharma Ltd.

https://www.citipharma.com.pk/

Citi Pharma Ltd. is a prominent pharmaceutical company specializing in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. It is a leading producer of Active Pharmaceutical Ingredients (APIs), with key products including Paracetamol, Penicillin, and Amoxicillin. The company delivers high-quality pharmaceutical services to a global market while maintaining a significant presence in local API manufacturing. Citi Pharma is dedicated to expanding its generic pharmaceutical portfolio and is actively engaged in research and development, notably in developing locally manufactured insulin to reduce import reliance. The company is also strategically advancing into biotechnology and oncology, driven by innovation and strategic collaborations, such as those with the Gates Foundation, to integrate advanced biotech technologies.

Recent filings

Filing Released Lang Actions
CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS
Regulatory Filings
2025-10-16 English
Transmission of Annual Report for the Year Ended
Regulatory Filings
2025-10-07 English
Notice of Annual General Meeting
Regulatory Filings
2025-10-06 English
Financial Results for the year ended
Regulatory Filings
2025-10-02 English
Material Information
Regulatory Filings
2025-09-12 English
Certified Copy of the Resolutions adopted in the Extra Ordinary General Meeting of Citi Pharma Limited , held on Thursday 26 June 2025
Regulatory Filings
2025-06-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.